Benbrook DM - Search Results

1

Synthesis and characterization of heteroarotinoids demonstrate structure specificity relationships.

Benbrook DM, Subramanian S, Gale JB, Liu S, Brown CW, Boehm MF, Berlin KD. Benbrook DM, et al. J Med Chem. 1998 Sep 10;41(19):3753-7. doi: 10.1021/jm980308p. J Med Chem. 1998. PMID: 9733501

2

Biological assay for activity and molecular mechanism of retinoids in cervical tumor cells.

Benbrook DM, Lu S, Flanagan C, Shen-Gunther J, Angros LH, Lightfoot SA. Benbrook DM, et al. Gynecol Oncol. 1997 Jul;66(1):114-21. doi: 10.1006/gyno.1997.4736. Gynecol Oncol. 1997. PMID: 9234931

3

Biologically active heteroarotinoids exhibiting anticancer activity and decreased toxicity.

Benbrook DM, Madler MM, Spruce LW, Birckbichler PJ, Nelson EC, Subramanian S, Weerasekare GM, Gale JB, Patterson MK Jr, Wang B, Wang W, Lu S, Rowland TC, DiSivestro P, Lindamood C 3rd, Hill DL, Berlin KD. Benbrook DM, et al. J Med Chem. 1997 Oct 24;40(22):3567-83. doi: 10.1021/jm970196m. J Med Chem. 1997. PMID: 9357524

4

Retinoid signaling in immortalized and carcinoma-derived human uroepithelial cells.

Waliszewski P, Waliszewska M, Gordon N, Hurst RE, Benbrook DM, Dhar A, Hemstreet GP 3rd. Waliszewski P, et al. Among authors: benbrook dm. Mol Cell Endocrinol. 1999 Feb 25;148(1-2):55-65. doi: 10.1016/s0303-7207(98)00235-4. Mol Cell Endocrinol. 1999. PMID: 10221771

5

Synthesis, structure-activity relationships, and RARgamma-ligand interactions of nitrogen heteroarotinoids.

Dhar A, Liu S, Klucik J, Berlin KD, Madler MM, Lu S, Ivey RT, Zacheis D, Brown CW, Nelson EC, Birckbichler PJ, Benbrook DM. Dhar A, et al. Among authors: benbrook dm. J Med Chem. 1999 Sep 9;42(18):3602-14. doi: 10.1021/jm9900974. J Med Chem. 1999. PMID: 10479291

6

Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors.

Zacheis D, Dhar A, Lu S, Madler MM, Klucik J, Brown CW, Liu S, Clement F, Subramanian S, Weerasekare GM, Berlin KD, Gold MA, Houck JR Jr, Fountain KR, Benbrook DM. Zacheis D, et al. Among authors: benbrook dm. J Med Chem. 1999 Oct 21;42(21):4434-45. doi: 10.1021/jm990292i. J Med Chem. 1999. PMID: 10543887

7

Complexity, retinoid-responsive gene networks, and bladder carcinogenesis.

Hurst RE, Waliszewski P, Waliszewska M, Bonner RB, Benbrook DM, Dar A, Hemstreet GP 3rd. Hurst RE, et al. Among authors: benbrook dm. Adv Exp Med Biol. 1999;462:449-67. doi: 10.1007/978-1-4615-4737-2_35. Adv Exp Med Biol. 1999. PMID: 10599447 Review.

8

Effects of retinoids on cancerous phenotype and apoptosis in organotypic cultures of ovarian carcinoma.

Guruswamy S, Lightfoot S, Gold MA, Hassan R, Berlin KD, Ivey RT, Benbrook DM. Guruswamy S, et al. Among authors: benbrook dm. J Natl Cancer Inst. 2001 Apr 4;93(7):516-25. doi: 10.1093/jnci/93.7.516. J Natl Cancer Inst. 2001. PMID: 11287445

9

Heterocycle-containing retinoids. Discovery of a novel isoxazole arotinoid possessing potent apoptotic activity in multidrug and drug-induced apoptosis-resistant cells.

Simoni D, Roberti M, Invidiata FP, Rondanin R, Baruchello R, Malagutti C, Mazzali A, Rossi M, Grimaudo S, Capone F, Dusonchet L, Meli M, Raimondi MV, Landino M, D'Alessandro N, Tolomeo M, Arindam D, Lu S, Benbrook DM. Simoni D, et al. Among authors: benbrook dm. J Med Chem. 2001 Jul 5;44(14):2308-18. doi: 10.1021/jm0010320. J Med Chem. 2001. PMID: 11428925

10

Refining retinoids with heteroatoms.

Benbrook DM. Benbrook DM. Mini Rev Med Chem. 2002 Jun;2(3):277-83. doi: 10.2174/1389557023406160. Mini Rev Med Chem. 2002. PMID: 12370069 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters